Exposure to antibiotics induces expression of the Mycobacterium tuberculosis sigF gene: Implications for chemotherapy against mycobacterial persistors

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 218-225

  Michele, Theresa M ^c   Ko, Chiew ^a,b   Bishai, William R ^a,b,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CUMENE HYDROPEROXIDE; CYCLOSERINE; ETHAMBUTOL; HYDROGEN PEROXIDE; LUCIFERASE; METRONIDAZOLE; RIFAMPICIN; SIGMA FACTOR; STREPTOMYCIN; TRANSCRIPTION FACTOR;

ANAEROBIC METABOLISM; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIOPHAGE; CHEMOTHERAPY; COLD STRESS; COLONY FORMING UNIT; DRUG EXPOSURE; GENE EXPRESSION; HEAT SHOCK; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXIDATIVE STRESS; PERSISTENT INFECTION; PLASMID; PRIORITY JOURNAL; REPORTER GENE;

EID: 0033065469     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.218     Document Type: Article

References (47)

1. Alcaide, F., G. E. Pfyffer, and A. Telenti. 1997. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob. Agents Chemother. 41:2270-2273.
2. American Thoracic Society. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. Am. J. Respir. Crit. Care Med. 149:1359-1374.
3. Antelmann, H., S. Engelmann, R. Schmid, and M. Hecker. 1996. General and oxidative stress responses in Bacillus subtilis: cloning, expression, and mutation of the alkyl hydroperoxide reductase operon. J. Bacteriol. 178: 6571-6578.
4. Ausubel, F., R. Brent, R. Kingston, D. Moore, J. Seidman, J. Smith, and K. Struhl. 1989. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
5. Barcak, G. J., M. S. Chandler, R. J. Redfield, and J. Tomb. 1991. Genetic systems in Haemophilus influenzae. Methods Enzymol. 204:321-342.
6. Bethesda Research Laboratories. 1986. BRL pUC host: E. coli DH5α™ competent cells, p. 9. In Bethesda Research Laboratory Focus, vol. 8. Bethesda Research Laboratories, Gaithersburg, Md.
7. Blanchard, J. S. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. Biochem. 65:215-239.
8. Caceres, N. E., N. B. Harris, J. F. Wellehan, Z. Feng, V. Kapur, and R. G. Barletta. 1997. Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis. J. Bacteriol. 179:5046-5055.
9. Cole, S. T. 1994. Mycobacterium tuberculosis: drug-resistance mechanisms. Trends Microbiol. 2:411-415.
10. Collins, D., R. Kawakami, G. de Lisle, L. Pascopella, B. Bloom, and W. Jacobs, Jr. 1995. Mutation of the principal σ factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 92:8036-8040.
11. DeMaio, J., Y. Zhang, C. Ko, and W. R. Bishai. 1997. The Mycobacterium tuberculosis sigF gene is part of a gene cluster organized like the Bacillus subtilis sigF and sigB operons. Tubercle Lung Dis. 78:3-12.
12. DeMaio, J., Y. Zhang, C. Ko, D. Young, and W. Bishai. 1996. A stationary phase stress-response sigma factor from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 93:2790-2794.
13. Deretic, V., M. Schurr, J. Boucher, and D. Martin. 1994. Conversion of Pseudomonas aeruginosa to mucoidy in cystic fibrosis: environmental stress and regulation of bacterial virulence by alternative sigma factors. J. Bacteriol. 176:2773-2780.
14. Donnelly-Wu, M. K., W. R. Jacobs, Jr., and G. F. Hatfull. 1993. Superinfection immunity of mycobacteriophage L5: applications for genetic transformation of mycobacteria. Mol. Microbiol. 7:407-417.
15. Gomez, J. E., and W. R. Bishai. 1998. Unpublished data.
16. Gomez, M., L. Doukhan, G. Nair, and I. Smith. 1998. sigA is an essential gene in Mycobacterium smegmatis. Mol. Microbiol. 29:617-628.
17. Goodell, E. W., M. Fazio, and A. Tomasz. 1978. Effect of benzylpenicillin on the synthesis and structure of the cell envelope of N. gonorrhoeae. Antimicrob. Agents Chemother. 13:514-526.
18. Grange, J. M. 1978. Fluorimetric assay of mycobacterial group-specific hydrolase enzymes. J. Clin. Pathol. 31:378-381.
19. Haas, F., and S. S. Haas. 1996. The origins of Mycobacterium tuberculosis and the notion of its contagiousness, p. 3-19. In W. N. Rom and S. M. Garay (ed.), Tuberculosis. Little, Brown & Co., New York, N.Y.
20. Handwerker, S., and A. Tomasz. 1985. Antibiotic tolerance among clinical isolates of bacteria. Annu. Rev. Pharmacol. Toxicol. 25:349-380.
21. Horne, D., and A. Tomasz. 1981. pH dependent penicillin tolerance of group B streptococci. Antimicrob. Agents Chemother. 20:128-135.
22. Howard, N. S., J. E. Gomez, C. Ko, and W. R. Bishai. 1995. Color selection with a hygromycin-resistance-based Escherichia coli-mycobacterial shuttle vector. Gene 166:181-182.
23. Jacobs, W., Jr., G. Kalpana, J. Cirillo, L. Pascopella, S. Snapper, R. Udani, W. Jones, R. Barletta, and B. Bloom. 1991. Genetic systems for mycobacteria. Methods Enzymol. 204:537-555.
24. Jacobs, W. R., Jr., R. G. Barletta, R. Udani, J. Chan, G. Kalkut, G. Sosne, T. Keiser, G. J. Sarkis, G. F. Hatfull, and B. R. Bloom. 1993. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 260:819-822.
25. Jawetz, E., J. B. Gunnison, R. S. Speck, and V. R. Coleman. 1951. Studies on antibiotic synergism and antagonism. Arch. Intern. Med. 87:349-359.
26. Jolliffe, L. K., R. J. Doyle, and U. N. Streips. 1982. Extracellular proteases increase tolerance of Bacillus subtilis to nafcillin. Antimicrob. Agents Chemother. 22:83-89.
27. Lee, M. H., L. Pascopella, W. R. Jacobs, Jr., and G. F. Hatfull. 1991. Site-specific integration of mycobacteriophage L5: integration-proficient vectors for Mycobacterium smegmatis, Mycobacterium tuberculosis, and bacille Calmette-Guerin. Proc. Natl. Acad. Sci. USA 88:3111-3115.
28. Miller, J. 1972. Experiments in molecular genetics. Cold Spring Laboratory, Cold Spring Harbor, N.Y.
29. Mitchison, D. A. 1992. The Garrod Lecture: understanding the chemotherapy of tuberculosis - current problems. J. Antimicrob. Chemother. 29:477-493.
30. Musser, J. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
31. Nesbit, C. E., M. E. Levin, M. K. Donnelly-Wu, and G. F. Hatfull. 1995. Transcriptional regulation of repressor synthesis in mycobacteriophage L5. Mol. Microbiol. 17:1045-1056.
32. O'Brien, R. J., and A. A. Vernon. 1998. New tuberculosis drug development: how can we do better? Am. J. Respir. Crit. Care Med. 157:1705-1707.
33. Pablos-Mendez, A., M. C. Raviglione, A. Laszlo, N. Binkin, H. L. Rieder, F. Bustreo, D. L. Cohn, C. S. B. Lambregts-van Weezenbeek, S. J. Kim, P. Chaulet, and P. Nunn. 1998. Global surveillance for antituberculosis-drug resistance, 1994-1997. N. Engl. J. Med. 338:1641-1649.
34. Parrish, N., J. Dick, and W. R. Bishai. 1998. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6:107-112.
35. Rajashekaraiah, K. R., T. Rice, V. S. Rao, D. Marsh, B. Ramakrishna, and C. A. Kalick. 1980. Clinical significance of tolerant strains of Staphylococcus aureus in patients with endocarditis. Ann. Intern. Med. 93:796-782.
36. Raviglione, M., D. E. Snider, and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273: 220-226.
37. Samarawickrema, N. A., D. M. Brown, J. A. Upcroft, N. Thammapalerd, and P. Upcroft. 1997. Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolitica. J. Antimicrob. Chemother. 40:833-840.
38. Sarkis, G. J., W. R. Jacobs, Jr., and G. F. Hatfull. 1995. L5 luciferase reporter mycobacteriophages: a sensitive tool for the detection and assay of live mycobacteria. Mol. Microbiol. 15:1055-1067.
39. Storch, G. A., D. J. Krogstad, and A. Parquette. 1981. Antibiotic induced lysis of enterococci. J. Clin. Invest. 68:639-645.
40. Tomasz, A., A. Albino, and E. Zanati. 1970. Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227:138-140.
41. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
42. Wayne, L. G., and H. A. Sramek. 1994. Metronidazole is bactericidal to dormant cells of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 38:2054-2058.
43. B and its role in acid tolerance and virulence of Listeria monocytogenes. J. Bacteriol. 180:3650-3656.
44. Wu, Q.-L., D. Kong, K. Lam, and R. N. Husson. 1997. A mycobacterial extracytoplasmic function sigma factor involved in survival following stress. J. Bacteriol. 179:2922-2929.
45. Wu, S., H. deLencastre, and A. Tomasz. 1996 Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing. J. Bacteriol. 178:6036-6042.
46. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-119.
47. Zhang, Y., R. Lathigra, T. Garbe, D. Catty, and D. Young. 1991. Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis. Mol. Microbiol. 5:381-391.